Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Congenital Hematological Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04289311
What this trial is testing

SMYLS: A Self-management Program for Youth Living With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Medical University of South Carolina 30
Not applicableStudy completedNCT01053715
What this trial is testing

Quality of Life Study of Helixate NexGen

Who this might be right for
Hemophilia A
CSL Behring 78
Early research (Phase 1)UnknownNCT05703204
What this trial is testing

QLF32101 in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid Leukemia and Myelodysplastic Syndrome
Qilu Pharmaceutical Co., Ltd. 122
Large-scale testing (Phase 3)Study completedNCT00243659
What this trial is testing

Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery

Who this might be right for
Hemophilia A
Wyeth is now a wholly owned subsidiary of Pfizer 30
Not applicableLooking for participantsNCT06919224
What this trial is testing

Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Ohio State University 287
Testing effectiveness (Phase 2)Study completedNCT02212535
What this trial is testing

Assessment of Tolerance of Mobilizing Peripheral Hematopoietic Stem Cells by Plerixafor in Sickle Cell Patients

Who this might be right for
Major Sickle Cell Syndrome of Type SS or Sβ Thalassemia
Assistance Publique - Hôpitaux de Paris 3
Very early researchStudy completedNCT06024876
What this trial is testing

A Clinical Study Evaluating the Safety and Efficacy of CS-101 in Treating Subjects With β-thalassemia

Who this might be right for
Beta-Thalassemia
CorrectSequence Therapeutics Co., Ltd 5
Early research (Phase 1)Looking for participantsNCT06817590
What this trial is testing

Nucleoside Therapy in Patients With Telomere Biology Disorders

Who this might be right for
Telomere Biology DisordersDyskeratosis CongenitaRevesz Syndrome+4 more
Suneet Agarwal 36
Large-scale testing (Phase 3)Study completedNCT01380197
What this trial is testing

Choosing Opioid Management for Pain and Analyzing Acute Chest Syndrome (ACS) Rates Equally

Who this might be right for
PainSickle Cell Disease
Children's Healthcare of Atlanta 40
Not applicableLooking for participantsNCT06573723
What this trial is testing

Institutional Registry of Rare Diseases

Who this might be right for
Rare DiseasesAmyloidosisSarcoidosis+23 more
Hospital Italiano de Buenos Aires 380
Not applicableStudy completedNCT00005559
What this trial is testing

Statistical Basis for Hemochromatosis Screening

Who this might be right for
Blood DiseaseHemochromatosis
National Heart, Lung, and Blood Institute (NHLBI)
Testing effectiveness (Phase 2)Ended earlyNCT00115349
What this trial is testing

Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases

Who this might be right for
Cardiovascular DiseasesHeart DiseasesBeta-Thalassemia
Carelon Research 20
Post-approval studies (Phase 4)Study completedNCT01735955
What this trial is testing

Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study

Who this might be right for
Chronic Myelogenous Leukemia (CML)Metastatic Gastrointestinal Stromal Tumors (GIST)Acute Lymphoblastic Leukemia (ALL)+1 more
Novartis Pharmaceuticals 57
Not applicableStudy completedNCT02114515
What this trial is testing

PATient Navigator to rEduce Readmissions

Who this might be right for
Chronic Obstructive Pulmonary DiseaseHeart FailureSickle Cell Disease+2 more
University of Illinois at Chicago 1,029
Not applicableLooking for participantsNCT07766135
What this trial is testing

Liver and Coagulation Disorders in Cardiac Transthyretin Amyloidosis

Who this might be right for
Transthyretin (TTR) Amyloid CardiomyopathyCardiac AmyloidosisCardiomyopathies+2 more
University of Messina 70
Not applicableStudy completedNCT00789516
What this trial is testing

The Change of Coagulation Markers in Children With β-thalassemia Disease After Stem Cell Transplantation

Who this might be right for
Thalassemia
Mahidol University 60
Not applicableStudy completedNCT03405402
What this trial is testing

Transfusion in Sickle Cell Disease: Risk Factors for Alloimmunization

Who this might be right for
Sickle Cell Disease
Hanane EL KENZ 173
Large-scale testing (Phase 3)UnknownNCT02921945
What this trial is testing

Efficacy and Safety Study of SCT800 for On-demand Treatment With in Patients With Hemophilia A

Who this might be right for
Hemophilia A
Sinocelltech Ltd. 50
Not applicableNot Yet RecruitingNCT07315126
What this trial is testing

Reliability of Transcutaneous Bilirubin Measurement According to the Skin Colour of Newborns

Who this might be right for
Neonatal Jaundice
Assistance Publique - Hôpitaux de Paris 510
Not applicableEnded earlyNCT05395858
What this trial is testing

Learn More About Treatment With Damoctocog Alfa Pegol, How it is Used in Every Day Practice ("Real-World"), and How Satisfied People Who Receive Damoctocog Alfa Pegol Are in United States (US) Hemophilia Treatment Centers

Who this might be right for
Hemophilia A
Bayer 14
Next Page